Xiaoyang Lu (Lu Xiaoyang)

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 6

Top Topics

Venous Thromboembolism

Walled Carbon Nanotubes

Oral Anticoagulants

Top Venues

Journal of clinical pharmacy and therapeutics

Journal of nanobiotechnology

Stem cells international

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lu Li, Li Zhitao, Cui Nannan, Huang Mingzhu, Hu Xiaoping, Hong Dongsheng, Zongfu Pan, Xiaoyang Lu
Mitofusin2 Promotes β Cell Maturation from Mouse Embryonic Stem Cells via Sirt3/Idh2 Activation. Stem cells international 2022 (2022)
Xiaojuan Wang, Xiaoling Xu, Shaojun Zhang, Na Chen, Yunfeng Sun, Kuifen Ma, Dongsheng Hong, Lu Li, Yong-Zhong Du, Xiaoyang Lu, Saiping Jiang
TPGS-based and S-thanatin functionalized nanorods for overcoming drug resistance in Klebsiella pneumonia. Nature communications 13 (1) (2022)
Lin Liu, Wendong Yao, Xiaowei Xie, Jianqing Gao, Xiaoyang Lu
pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia. Journal of nanobiotechnology 19 (1) (2021)
Lin Liu, Jiahe Wu, Jianqing Gao, Xiaoyang Lu
Bacteria-Derived Nanoparticles: Multifunctional Containers for Diagnostic and Therapeutic Applications. Advanced healthcare materials 9 (22) (2020)
Lin Liu, Dongsheng Hong, Kuifen Ma, Xiaoyang Lu
Cost-effectiveness of rivaroxaban versus warfarin in non-valvular atrial fibrillation patients with chronic kidney disease in China. Journal of clinical pharmacy and therapeutics 46 (3) (2020)
Jiaying Wu, Yuyu Zhang, Hongyu Yang, Yuefeng Rao, Jing Miao, Xiaoyang Lu
Intestinal Microbiota as an Alternative Therapeutic Target for Epilepsy. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2016 (2016)